Abbott Vascular

Abbott advanced to the forefront of vascular care with the acquisition of Guidant’s vascular business in 2006. The transaction significantly and immediately expanded our commercial, manufacturing, and research and development capabilities and built leadership positions across three distinct businesses — coronary, endovascular and vessel closure.

Anatomy of a growth strategy

Vascular care is one of the most promising and rapidly growing fields in medical devices — and the acquisition of Guidant’s vascular business was a significant advance toward building a world-class vascular device company at Abbott. It added a next-generation drug-eluting stent, Xience V, a second carotid stent platform and a robust pipeline to an already growing base of endovascular and vessel closure technologies.

Building Abbott Vascular:

1999
Entered the vascular market by acquiring the vessel closure company, Perclose Inc.

2001
Partnered with MedNova Ltd. to develop carotid stent and embolic protection products.

2004
Launched the StarClose vessel closure device.

2005
Achieved double-digit sales growth for Abbott Vascular. Launched the Xact and Emboshield carotid stent platform.

2006
Acquired Guidant’s vascular business. Achieved more than $1 billion in annual sales. Launched Xience V in Europe and Asia.

Xience V

Xact/RX Acculink

StarClose

Endovascular
Carotid and peripheral stenting is an emerging frontier of vascular disease treatment. Abbott is the only company offering two distinct carotid stents and embolic protection systems, providing a choice to best meet patient and physician needs.

Coronary
A leader in interventional cardiology, Abbott offers a complete portfolio of innovative products for cardiovascular disease, including a next-generation drug-eluting stent, Xience V, and the market-leading metallic stent, Multi-Link Vision.

Vessel Closure
Abbott is a pioneer in developing closure technologies, such as StarClose, designed to facilitate secure closure of the femoral artery in a matter of seconds.

Page Top